1-(2-(decylthio)ethyl)azacyclopentane-2-one and Diseases, Peripheral Vascular

1-(2-(decylthio)ethyl)azacyclopentane-2-one has been researched along with Diseases, Peripheral Vascular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adachi, H; Irie, T; Manako, T; Saita, M; Uekama, K; Yano, T	1

Other Studies

1 other study(ies) available for 1-(2-(decylthio)ethyl)azacyclopentane-2-one and Diseases, Peripheral Vascular

Article	Year
Inhibitory effect of prostaglandin E1 on laurate-induced peripheral vascular occlusive sequelae in rabbits: optimized topical formulation with beta-cyclodextrin derivative and penetration enhancer HPE-101. The Journal of pharmacy and pharmacology, 1992, Volume: 44, Issue:12 Topics: Administration, Topical; Alprostadil; Animals; Cyclodextrins; Drug Carriers; Drug Combinations; Ear; Lauric Acids; Male; Ointments; Peripheral Vascular Diseases; Pyrroles; Rabbits	1992

Article

Year

Inhibitory effect of prostaglandin E1 on laurate-induced peripheral vascular occlusive sequelae in rabbits: optimized topical formulation with beta-cyclodextrin derivative and penetration enhancer HPE-101.

The Journal of pharmacy and pharmacology, 1992, Volume: 44, Issue:12

Topics: Administration, Topical; Alprostadil; Animals; Cyclodextrins; Drug Carriers; Drug Combinations; Ear; Lauric Acids; Male; Ointments; Peripheral Vascular Diseases; Pyrroles; Rabbits

1992